日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial

米氮平治疗甲基苯丙胺使用障碍:一项随机临床试验

McKetin, Rebecca; Shoptaw, Steven; Saunders, Lucy; Nguyen, Long; Clare, Philip J; Dore, Gregory J; Turner, Alyna; Dean, Olivia M; Kelly, Peter J; Arunogiri, Shalini; Koeijers, Juanita; Degan, Tayla J; Degenhardt, Louisa; Farrell, Michael; Goodman-Meza, David; Sinclair, Barbara; Reid, David; Cordaro, Frank; Hill, Harry; Lundin, Robert; Hayllar, Jeremy; Christmass, Michael; Liaw, Willy; Liu, Danica; Woods, Amelia; Brewerton, Blaire; Holyoak, Ellie; Wu, Brian Tid-Fung; Maher, Hayley; O'Dea, Noni; Keygan, Joel; Kontogiannis, Ava; Palmer, Lily; Morrison, Caity; Wrobel, Anna; Hyland, Bec; Kiden, Gift; Romeo, Vanessa; Kyaw, Khine Wut Yee; Byrne, Marianne; Colledge-Frisby, Samantha; Zahra, Emma; Berk, Michael

Trial protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)

一项开放标签试点研究的试验方案,该研究旨在评估口服纳曲酮-安非他酮联合药物疗法治疗甲基苯丙胺使用障碍的疗效(NABU 试验)。

Siefried, Krista J; Acheson, Liam; Clifford, Brendan; Moller, Carl; Brett, Jonathan; Christmass, Michael; Dunlop, Adrian John; Haber, Paul S; Jutras-Aswad, Didier; Lintzeris, Nicholas; Morley, Kirsten; Shoptaw, Steven; Trivedi, Madhukar H; Ezard, Nadine

Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings

一项随机对照试验的研究方案,旨在确定赖右苯丙胺在住院患者中治疗急性甲基苯丙胺戒断症状的疗效。

Acheson, Liam S; Siefried, Krista J; Lintzeris, Nicholas; Dunlop, Adrian J; Haber, Paul S; Arunogiri, Shalini; Christmass, Michael; Doyle, Michael; Donoghoe, Mark; Nagle, Jack; Clifford, Brendan; McKetin, Rebecca; Lubman, Dan I; Brett, Jonathan; Taylor, Nathan; Carr, Andrew; Levin, Frances R; Shoptaw, Steven; Ezard, Nadine

A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial

米氮平作为甲基苯丙胺使用障碍药物治疗的3期随机双盲安慰剂对照试验:Tina试验的研究方案

McKetin, Rebecca; Degan, Tayla J; Saunders, Lucy; Nguyen, Long; Dore, Gregory; Shoptaw, Steven; Farrell, Michael; Degenhardt, Louisa; Kelly, Peter J; Turner, Alyna; Clare, Philip J; Dean, Olivia M; Arunogiri, Shalini; Colledge-Frisby, Samantha; Koeijers, Juanita; Goodman-Meza, David; Sinclair, Barbara; Reid, David; Hill, Harry; Hayllar, Jeremy; Christmass, Michael; Cordaro, Frank; Lundin, Robert; Liaw, Willy; Liu, Danica; Holyoak, Ellie; Wu, Brian Tid-Fung; Keygan, Joel; Kontogiannis, Ava; Palmer, Lily; Morrison, Caity; Wrobel, Anna; Hyland, Bec; Byrne, Marianne; Russell, Samantha; Zahra, Emma; Berk, Michael

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

一项开放标签试点研究的试验方案,该研究旨在评估赖右苯丙胺治疗急性甲基苯丙胺戒断症状的疗效。

Acheson, Liam S; Ezard, Nadine; Lintzeris, Nicholas; Dunlop, Adrian; Brett, Jonathan; Rodgers, Craig; Gill, Anthony; Christmass, Michael; McKetin, Rebecca; Farrell, Michael; Shoptaw, Steve; Siefried, Krista J

A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia

澳大利亚一项关于甲基苯丙胺和新兴关注毒品使用相关问题的临床研究优先事项设定研究

Siefried, Krista J; Ezard, Nadine; Christmass, Michael; Haber, Paul; Ali, Robert

Mandatory treatment for methamphetamine use in Australia

澳大利亚强制治疗甲基苯丙胺滥用者

Coleman, Mathew; Ridley, Kelly; Christmass, Michael